PLR

Protective Life Insurance Company Receives Favorable Private Letter Ruling on Advisory VUL Offering

Retrieved on: 
Tuesday, October 24, 2023
Professional Services, Insurance, Finance, Dai, Policy, VUL, IRS, RIA, RIAS, SVP, PLR, Internal Revenue Service, Business development, Protection, Private, Average revenue per user, Nashville, Tennessee, Registered investment adviser, Universal Life, Dai-ichi, 14th Railway Facilities Protection Division NKVD, Financial adviser

Protective Life Insurance Company (Protective), a subsidiary of Dai-ichi Life Holdings, Inc. (Dai-ichi, TSE:8750), announces the Private Letter Ruling (PLR) from the Internal Revenue Service (IRS) related to Protective’s fee-based advisory Variable Universal Life (VUL) offering.

Key Points: 
  • Protective Life Insurance Company (Protective), a subsidiary of Dai-ichi Life Holdings, Inc. (Dai-ichi, TSE:8750), announces the Private Letter Ruling (PLR) from the Internal Revenue Service (IRS) related to Protective’s fee-based advisory Variable Universal Life (VUL) offering.
  • This ruling, an industry first for a life insurance product, was issued on July 17, 2023, by the IRS regarding Protective’s Investors Benefit Advisory VUL offering.
  • “Having the first PLR issued for an advisory VUL offering shows Protective’s commitment to being an industry leader in fee-based insurance for Registered Investment Advisors (RIA),” said Chad Nulty, VP of Business Development for Protective’s RIA Insurance.
  • The Protective Investors Benefit Advisory VUL offering is issued by Protective (Nashville, Tenn.) in all states except New York on policy form ICC19-V15 and state variations thereof.

Global Pupillometer Market Analysis Report 2023: A $673.9 Million Market by 2030 - Digital and Video Pupillometers Transforming Diagnosis with Mobility and Efficiency - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 10, 2023
Optical, Health, Medical Devices, Prevalence, Nursing, Hospital, Overalls, DSM-IV codes, Pupilometer, USD, Pupillometry, PLR, Ophthalmology, Growth, Diagnosis, Digital, Heidelberg University Eye Clinic, Research, Pupil, Medical imaging, Video game

The global pupillometer market size is expected to reach USD 673.9 million by 2030, registering a CAGR of 6.85%

Key Points: 
  • The global pupillometer market size is expected to reach USD 673.9 million by 2030, registering a CAGR of 6.85%
    Adoption of pupillometry is on the rise as an assessment examination for diagnosing various health conditions.
  • This growth in adoption is leading to the development of advanced pupillometer devices for faster and more accurate diagnosis.
  • Pupillometers are widely being used in critical care units, as pupillometry is becoming a protocol for primary diagnosis.
  • Video pupillometer is preferred more, as it helps in capturing the entire procedure of pupil dilation in a more detailed manner.

BeiGene Presentations at the 2023 ASCO Annual Meeting Reinforce Promise Across Oncology Portfolio

Retrieved on: 
Thursday, May 25, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Abstract (summary), Rituximab, Obinutuzumab, BGNE, EU, Doctor of Philosophy, Hepatocellular carcinoma, Lymphoid leukemia, NA, Lenalidomide, OS, Trae tha Truth, Head, Toxicity, Multimedia, BCLC, Lung cancer, ASCO, PLR, Incidence, SSE, OX40, American Society of Clinical Oncology, Patient, Sorafenib, NLR, Annual general meeting, Bone marrow, Abstract, Society, ORR, Tislelizumab, Pharmaceutical industry, Vaccine, Flour, BeiGene

These results include data for BeiGene’s cornerstone therapies, BRUKINSA® (zanubrutinib) and tislelizumab, as well as early results for BeiGene’s OX40 agonist and BCL-2 inhibitor.

Key Points: 
  • These results include data for BeiGene’s cornerstone therapies, BRUKINSA® (zanubrutinib) and tislelizumab, as well as early results for BeiGene’s OX40 agonist and BCL-2 inhibitor.
  • These results will be presented on Monday, June 5, as poster presentations from 8:00-11:00 a.m. CT. (Abstracts #4082 and #4083).
  • BGB-11417 monotherapy also showed promising initial efficacy results in R/R chronic lymphocytic leukemia/small lymphocytic lymphoma, with patients achieving responses at lower dose levels.
  • These results will be presented on Monday, June 5, as a poster presentation from 8:00-11:00 a.m. CT (Abstract #7558).

Jefferies Board of Directors Declares Spin-Off Dividend of Vitesse Energy Common Stock

Retrieved on: 
Saturday, December 17, 2022
Professional Services, Finance, Indian stock exchange, Register, NYSE, Failure, Nature, JEF, Disclosure, Information, State Street Bank & Trust Co. v. Signature Financial Group, Inc., PLR, Condition, Internal Revenue Service, Common, Revenue stream, Research, Jefferies Financial Group, IRS, Security (finance), Jefferies, Vitesse

Jefferies Financial Group Inc. (NYSE:JEF) (“Jefferies”) today announced that its Board of Directors has declared a pro rata dividend of the outstanding shares of common stock (the “Vitesse Common Stock”) of Vitesse Energy, Inc. (“Vitesse”) held by Jefferies to the holders of record of the common shares of Jefferies (the “Jefferies Common Shares”) as of 5:00 p.m.

Key Points: 
  • Jefferies Financial Group Inc. (NYSE:JEF) (“Jefferies”) today announced that its Board of Directors has declared a pro rata dividend of the outstanding shares of common stock (the “Vitesse Common Stock”) of Vitesse Energy, Inc. (“Vitesse”) held by Jefferies to the holders of record of the common shares of Jefferies (the “Jefferies Common Shares”) as of 5:00 p.m.
  • Jefferies shareholders will retain their current Jefferies Common Shares and, on the distribution date, each holder of Jefferies Common Shares will also receive, for every 8.49668 Jefferies Common Shares owned as of the record date, a distribution of one share of Vitesse Common Stock.
  • Fractional shares of Vitesse Common Stock will not be distributed to Jefferies shareholders.
  • No action or payment is required by Jefferies shareholders to receive the shares of Vitesse Common Stock or cash in lieu of fractional shares.

Light Weapons Global Market Report 2022: A $12.8+ Billion Market in 2026 Featuring Leading Players - Lockheed Martin, Alliant Techsystems, Rheinmetall, Raytheon Technologies, & Thales Group - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 15, 2022
Other Defense, Defense, CRPF, Acquisition, Bangladesh Navy, Night vision, Steel, MANPADS, Law enforcement, Person, Single person, Weapon, Adani Group, Violence, MANPAD, Adani, Criminal code, Bangladesh, Polymer, Crime, Laser, Organization, Growth, HMG, Arm, War, Terror, IPC, SLL, ATW, Drug, Pulwama, PLR

The main types of light weapons includes HMG, light cannon, MANPAT, mortar, MANPAD, grenades, missiles, launcher, ATW and landmine.

Key Points: 
  • The main types of light weapons includes HMG, light cannon, MANPAT, mortar, MANPAD, grenades, missiles, launcher, ATW and landmine.
  • These weapons are made from materials such as steel and polymers technologies used in these weapons include guided and unguided.
  • The regions covered in the light weapons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The countries covered in the light weapons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

NeurOptics’ Neurological Pupil index™ and Automated Pupillometry Included in Latest European Guidelines for Post-Resuscitation Care

Retrieved on: 
Tuesday, December 13, 2022
Health Technology, Data Management, Technology, Practice Management, Optical, Managed Care, General Health, Medical Devices, Hospitals, Cardiology, Software, Networks, Nursing, Health, Medical Supplies, Consensus, ECC, Prognosis, Cardiopulmonary resuscitation, Subjectivity, Neurological pupil index, European Society for Medical Oncology, ILCOR, ROSC, MD, Brain, Science, Doctor of Philosophy, International Liaison Committee on Resuscitation, ICU, Cardiac arrest, Patient, Erasmus, Research, Hospital, Resuscitation, Intensive care medicine, Neurosurgery, Business, Neurology, PLR, ERC, NPI, Journal, CPR, Emergency medicine, Multimedia, European Resuscitation Council, DOI, Neuromuscular blocking agents, Pupillometry, Pupilometer, Medical device, Pharmaceutical industry

NeurOptics Neurological Pupil index (NPi) and automated pupillometry are now included in the updated 2021 European Resuscitation Council (ERC) and European Society of Intensive Care Medicine (ESICM) Guidelines for post-resuscitation care as an objective measurement supporting neurological prognosis in patients following cardiac arrest.

Key Points: 
  • NeurOptics Neurological Pupil index (NPi) and automated pupillometry are now included in the updated 2021 European Resuscitation Council (ERC) and European Society of Intensive Care Medicine (ESICM) Guidelines for post-resuscitation care as an objective measurement supporting neurological prognosis in patients following cardiac arrest.
  • The guidelines were last updated in 2015 and reflect alignment with the International Liaison Committee on Resuscitation (ILCOR) and associated member councils.
  • NeurOptics NPi Pupillometry has emerged as an important technology that provides a quantitative measurement of pupil size and reactivity, expressed as the Neurological Pupil index (NPi).
  • : Adult advanced life support: 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations.

The Worldwide Pupillometer Industry is Expected to Reach $674 Million by 2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, December 5, 2022
Health, Optical, Diagnosis, Research, Pupillometry, Nursing, Prevalence, Hospital, PLR, Overalls, Pupil, Growth, Pupilometer, Medical imaging, Video game

This growth in adoption is leading to the development of advanced pupillometer devices for faster and more accurate diagnosis.

Key Points: 
  • This growth in adoption is leading to the development of advanced pupillometer devices for faster and more accurate diagnosis.
  • Moreover, understanding the changes occurring in pupil characteristics helps clinicians in performing various neurological surgeries.
  • Video pupillometer is preferred more, as it helps in capturing the entire procedure of pupil dilation in a more detailed manner.
  • The video pupillometer helps in capturing the pupil characteristics and its reactivity over time, which in turn is expected to enhance the diagnosis process.

InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel

Retrieved on: 
Wednesday, July 13, 2022
Health, Other Health, Managed Care, General Health, Research, Science, Biotechnology, The Washington Center, Hospital, Schwegman, Lundberg & Woessner, Business development, Stevens Point, Wisconsin, PAETEC Holding Corp., Spinal cord injury, Washington Center, William Mitchell College of Law, Therapy, Chemistry, Director, Massachusetts Institute of Technology, Patient, Invivo Wines, Massachusetts General Hospital, Private practice, PLR, Patent, Â, Harvard University, General counsel, Biochemistry, Research, Augustus A. Bird, Board, INSPIRE, University, Boston, Board of directors, Liberal arts education, Ecolab, Management, Technology

as its Chief Legal Officer and General Counsel.

Key Points: 
  • as its Chief Legal Officer and General Counsel.
  • Ms. Hamel will also be responsible for the oversight of certain other functions, including business development, human resources and external communications.
  • Prior to this appointment, Ms. Hamel served as the companys Vice President of Legal Affairs and Business Development.
  • Prior to InVivo, Ms. Hamel worked at Ecolab, Inc., where she oversaw a variety of legal matters including intellectual property strategy, patent prosecution and litigation management.

$21+ Billion Worldwide Hormonal Contraceptives Industry to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 16, 2021
Health, Pharmaceutical, Benchmark, Organic, Safety, STD, WHO, Pregnancy, United Nations Department of Economic and Social Affairs, USD, London Summit, World, World Health Organization, Ageing, Coronavirus, Ministry of Social Affairs, Private sector, Family planning 2020, Partnership, Woman, Awareness, Create, US, PLR, PLLR, Patient, FDA, Marketing, Pharmaceutical industry, Birth control

Increased awareness about the benefits and use of contraceptives is a major factor driving the hormonal contraceptives market.

Key Points: 
  • Increased awareness about the benefits and use of contraceptives is a major factor driving the hormonal contraceptives market.
  • FP2020 has created a momentum worldwide on issues such as access to contraceptives, more innovation, and greater accountability in family planning efforts.
  • Manufacturers in the hormonal contraceptives market should abide by many strict regulations with regards to labeling hormonal contraceptives, and are all supervised by regulatory authorities.
  • The ability to interact with specific targets puts these medicines above any other drugs, thus hampering the market of chemical hormonal contraceptive drugs.

ALCS Response to Autumn Budget and Spending Review

Retrieved on: 
Wednesday, October 27, 2021
Online, Government, Book, Public Lending Right, Treasury, Workforce, High Street, Society, Television, Review, Budget, Library, ALCS, COVID-19, APWG, PLR, Copyright, Renewable energy, Publishing, Pharmaceutical industry, Tourism

These stand at an unsustainable disadvantage to online retailers, who pay substantially less in business rates and corporation tax.

Key Points: 
  • These stand at an unsustainable disadvantage to online retailers, who pay substantially less in business rates and corporation tax.
  • We recognise the value these buildings hold to communities and the need for investment in cultural venues around the country.
  • ALCS is a not-for-profit organisation that benefits of all kinds of writers and currently has over 110,000 members.
  • As it is, the size of the PLR fund is relatively small and has not increased for years.